
GC19399
Derazantinib
Also known as (6R)-6-(2-fluorophenyl)-N-[3-[2-(2-methoxyethylamino)ethyl]phenyl]-5,6-dihydrobenzo[h]quinazolin-2-amine
Derazantinib is a novel, ATP competitive, small molecule, multi-kinase inhibitor with IC50 of 1·8nM for FGFR2, and 4·5nM for FGFR1 and 3
ChemicalCAS1234356-69-4MW468.57FormulaC29H29FN4O
- CAS number
- 1234356-69-4
- Molecular weight
- 468.57
- Formula
- C29H29FN4O
- Solubility
- DMSO : ≥ 100 mg/mL (213·42 mM)
- InChIKey
- KPJDVVCDVBFRMU-AREMUKBSSA-N
- Catalogue number
- GC19399
- Brand
- GLPBIO
Computed properties PubChem CID 46834118 · XLogP 5.3 · TPSA 59.1 Ų · H-bond donors 2
- XLogP
- 5.3
- TPSA
- 59.1 Ų
- H-bond donors
- 2
- H-bond acceptors
- 6
- Rotatable bonds
- 9
- Heavy atoms
- 35
SMILES COCCNCCC1=CC(=CC=C1)NC2=NC=C3C[C@H](C4=CC=CC=C4C3=N2)C5=CC=CC=C5F
Computed descriptors from PubChem (CID 46834118), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il